Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Tumor-Associated Trypsin Inhibitor"'
Autor:
Chuanliang Xu, Xu Gao, Anwei Liu, Zhensheng Zhang, Fei Liu, Yongping Xue, Haoyuan Tan, Shuxiong Zeng, Yinghao Sun, Qiao Xiong
Publikováno v:
Cancer biomarkers : section A of Disease markers. 26(3)
Background Urothelial carcinoma of the bladder is a heterogeneous disease for which reliable prognostic molecular biomarkers have not been established. Objective To investigate the prognostic value of tumor-associated trypsin inhibitor (TATI) express
Publikováno v:
Tumori Journal. 102:527-532
Aim The aim of the study was to look for prognostic factors of metastasis or recurrence in patients with endometrial cancer. Methods Tumor-associated trypsin inhibitor (TATI) concentrations were measured in serum of 317 patients with endometrial canc
Autor:
Arno Nordin, Helena Isoniemi, Ulf-Håkan Stenman, Ilana Lyytinen, Heikki Mäkisalo, Marko Lempinen
Publikováno v:
Scandinavian Journal of Gastroenterology. 48:1066-1073
Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third most frequent cause of cancer death worldwide. The aim of this study was to evaluate the prognostic value of serum tumor-associated trypsin inhibitor (TATI) and the free β
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Shailendra Kapoor
Publikováno v:
Scandinavian journal of gastroenterology. 49(4)
Autor:
Tramonti, G, Ferdeghini, Marco, Annichiarico, C, Donadio, C, Norpoth, M, Mantuano, E, Bianchi, C.
Publikováno v:
Journal of nephrology. 16(5)
Low molecular weight (LMW) proteins have been proposed for renal function assessment. This study aimed to ascertain the usefulness of tumor-associated trypsin inhibitor (TATI), a LMW protein (6.200 d), as a glomerular filtration rate (GFR) marker. Th
Autor:
Dimitrios Pectasides, A. Athanassiou, L. Gogou, N. Economides, P. Pozadzizou, P. Koutsiouba, J. Bourazanis
Publikováno v:
American Journal of Clinical Oncology. 17:307-312
A total of 120 patients with squamous cell carcinoma of the cervix were prospectively monitored with simultaneous serum level estimations of SCC, CEA, and TATI in different stages and phases of their disease. Positive values were observed for SCC in
Publikováno v:
Scandinavian Journal of Clinical and Laboratory Investigation. 51:11-13
Tumor-associated trypsin inhibitor (TATI) was assayed in healthy subjects and in women with benign and malignant gynecological diseases. Significantly lower levels were found in boys than in healthy adult subjects. No variations in level were evident
Publikováno v:
TUMOR BIOLOGY. 14(2):105-115
The CA 195 levels in ovarian cyst fluids from malignant mucinous tumours (median 2,300,000 U/ml) were significantly higher than the levels in benign mucinous tumours and malignant non-mucinous tumours (medians of 26,800 and 1,700 U/ml, respectively,
Autor:
J F Legorburu Escudero, A Loizate Toricaguena, A. Lamiquiz Vallejo, M.J. Dominguez Merru-Urrutia
Publikováno v:
Scandinavian Journal of Clinical and Laboratory Investigation. 51:59-62
We have evaluated the clinical utility of tumor-associated trypsin inhibitor (TATI) as a marker for gastric cancer. For comparison we also studied CEA, CA19-9, CA-50 and TPA. The study comprised 93 patients with cancer and 45 with gastroduodenal ulce